These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34509304)

  • 1. Efficacy and Tolerability of Cyproheptadine in Poor Appetite: A Multicenter, Randomized, Double-blind, Placebo-controlled Study.
    Kim SY; Yun JM; Lee JW; Cho YG; Cho KH; Park YG; Cho B
    Clin Ther; 2021 Oct; 43(10):1757-1772. PubMed ID: 34509304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy.
    Cuvelier GD; Baker TJ; Peddie EF; Casey LM; Lambert PJ; Distefano DS; Wardle MG; Mychajlunow BA; Romanick MA; Dix DB; Wilson BA
    Pediatr Blood Cancer; 2014 Apr; 61(4):672-9. PubMed ID: 24167059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial of cyproheptadine for appetite stimulation in cystic fibrosis.
    Epifanio M; Marostica PC; Mattiello R; Feix L; Nejedlo R; Fischer GB; Stein RT
    J Pediatr (Rio J); 2012; 88(2):155-60. PubMed ID: 22544046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effect of cyproheptadine on sleep and appetite disorders induced by methylphenidate: an exploratory randomised, double-blinded, placebo-controlled clinical trial.
    Kadkhoda Mezerji F; Moharreri F; Mohammadpour AH; Elyasi S
    Int J Psychiatry Clin Pract; 2019 Mar; 23(1):72-79. PubMed ID: 30261781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyproheptadine is an effective appetite stimulant in cystic fibrosis.
    Homnick DN; Homnick BD; Reeves AJ; Marks JH; Pimentel RS; Bonnema SK
    Pediatr Pulmonol; 2004 Aug; 38(2):129-34. PubMed ID: 15211696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cyproheptadine to stimulate appetite and body weight gain: A systematic review.
    Harrison ME; Norris ML; Robinson A; Spettigue W; Morrissey M; Isserlin L
    Appetite; 2019 Jun; 137():62-72. PubMed ID: 30825493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia.
    Kardinal CG; Loprinzi CL; Schaid DJ; Hass AC; Dose AM; Athmann LM; Mailliard JA; McCormack GW; Gerstner JB; Schray MF
    Cancer; 1990 Jun; 65(12):2657-62. PubMed ID: 2187585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term cyproheptadine therapy in underweight children: effects on growth and serum insulin-like growth factor-I.
    Mahachoklertwattana P; Wanasuwankul S; Poomthavorn P; Choubtum L; Sriphrapradang A
    J Pediatr Endocrinol Metab; 2009 May; 22(5):425-32. PubMed ID: 19618661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cyproheptadine on hunger, calorie intake and body weight in man.
    Silverstone T; Schuyler D
    Psychopharmacologia; 1975; 40(4):335-40. PubMed ID: 1096217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study.
    Potter P; Maspero JF; Vermeulen J; Barkai L; Németh I; Baillieau RA; Garde JM; Giralt J; Doménech A; Izquierdo I; Nieto A
    Pediatr Allergy Immunol; 2013 Mar; 24(2):144-50. PubMed ID: 23384091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of cyproheptadine on body mass index in undernourished children: a randomized controlled trial.
    Najib K; Moghtaderi M; Karamizadeh Z; Fallahzadeh E
    Iran J Pediatr; 2014 Dec; 24(6):753-8. PubMed ID: 26019782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term trial of cyproheptadine as an appetite stimulant in cystic fibrosis.
    Homnick DN; Marks JH; Hare KL; Bonnema SK
    Pediatr Pulmonol; 2005 Sep; 40(3):251-6. PubMed ID: 16015665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS
    Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyproheptadine on serum leptin levels.
    Calka O; Metin A; Dülger H; Erkoç R
    Adv Ther; 2005; 22(5):424-8. PubMed ID: 16418149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: A double-blind, randomized, multicenter, placebo-controlled clinical trial.
    Okubo K; Suzuki T; Tanaka A; Aoki H
    Allergol Int; 2019 Apr; 68(2):207-215. PubMed ID: 30391169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study.
    Garcia JM; Friend J; Allen S
    Support Care Cancer; 2013 Jan; 21(1):129-37. PubMed ID: 22699302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.